AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jun 17, 2022
50715_rns_2022-06-17_4372e982-3c15-4013-9cd5-3075610a3fd5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
17 June 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Description of relevant securities |
Description of products |
Nature of dealings |
Number of reference securities to which the derivatives relate |
Maturity date / closing out date |
Reference price |
Total amount paid / received |
Resultant balance (including those of any person with whom there is an agreement or understanding) |
|---|---|---|---|---|---|---|---|---|---|
| CICC Pucheng Investment Co., Ltd. |
16 June 2022 | Derivatives | Other types of products |
Closing out of a derivative contract |
6,000 | 22 May 2024 | $26.3000 | $157,800.0000 | 52,000 |
| Derivatives | Other types of products |
Closing out of a derivative contract |
4,000 | 19 February 2025 |
$26.3000 | $105,200.0000 | 70,000 | ||
| Derivatives | Other types of products |
Closing out of a derivative contract |
6,000 | 20 June 2023 | $26.3494 | $158,096.4300 | 52,000 |
Public Disclosure Form
==> picture [71 x 43] intentionally omitted <==
| Derivatives | Other types of products |
Closing out of a derivative contract |
4,000 | 20 June 2023 | $26.3494 | $105,397.6200 | 70,000 | ||
|---|---|---|---|---|---|---|---|---|---|
End
Note:
CICC Pucheng Investment Co., Ltd. is an exempt principal trader connected with the Offeror.
Dealings were made for its own account.
CICC Pucheng Investment Co., Ltd. is ultimately owned by China International Capital Corporation Limited.
More from CStone Pharmaceuticals
Regulatory Filings
2026
Jun 4
Director's Dealing
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 1
AGM Information
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
Jun 1
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27